Mandatory use of prescription drug monitoring programs

JAMA. 2015 Mar 3;313(9):891-2. doi: 10.1001/jama.2014.18514.

Authors

Rebecca L Haffajee¹, Anupam B Jena², Scott G Weiner³

Affiliations

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
² Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts3Massachusetts General Hospital, Boston4National Bureau of Economic Research, Cambridge, Massachusetts.
³ Division of Health Policy Research Translation, Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Drug Utilization / legislation & jurisprudence*
Drug and Narcotic Control / legislation & jurisprudence*
Humans
Mandatory Programs* / legislation & jurisprudence
Mandatory Programs* / statistics & numerical data
Prescription Drugs*
United States

Substances

Prescription Drugs

Grants and funding